Explore our limited-edition seasonal peptide bundles — crafted for cutting-edge research and available only while stocks last.
Retatrutide 20mg is a single-dose vial containing a high-potency, investigational tri-agonist peptide. It represents a novel class of therapeutic agents designed for the treatment of obesity, type 2 diabetes, and related metabolic conditions. As the highest dose in the clinical development program, the 20mg formulation is intended for use in a structured titration schedule to achieve significant and sustained metabolic control.
R3,000.00